Evidence map›Paper›PMID 34203304›Full record

ReviewGenes2021

Genotype-Phenotype Correlations in Angelman Syndrome.

Lili Yang, Xiaoli Shu, Shujiong Mao, Yi Wang, Xiaonan Du, Chaochun Zou

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Stem cell models of Angelman syndrome.Frontiers in cell and developmental biology · 2023
    Review
  20. Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lili YangDepartment of Genetics and Metabolism, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
Xiaoli ShuDepartment of Laboratory Center, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
Shujiong MaoDivision of Neonatology, Department of Pediatrics, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China.
Yi WangDepartment of Neurology, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiaonan DuDepartment of Neurology, Children's Hospital of Fudan University, Shanghai 201102, China.
Chaochun ZouDepartment of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
Children's Hospital of Zhejiang University · CNChildren's Hospital of Fudan University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angelman syndrome (AS) is a rare neurodevelopmental disease that is caused by the loss of function of the maternal copy of ubiquitin-protein ligase E3A (

Indexed as

Genetic Association StudiesAngelman SyndromeChromosomes, Human, Pair 15Genetic CounselingGenotypeHumansMutationPhenotypeSeizuresUbiquitin-Protein LigasesUBE3A protein, humanUbiquitin-Protein LigasesAngelman syndromegenotypeimprintingintellectual disabilityneurodevelopmentphenotype

Identifiers

PMID34203304
PMCPMC8304328
OpenAlexW3175353306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.